Press Releases

<< Back
Nov 3, 2014

Herbalife Ltd. Announces Third Quarter 2014 Results

 

  • Worldwide net sales grew 4 percent to $1.3 billion compared to $1.2 billion the prior year period
  • Adjusted1 EPS increased 3 percent to $1.45 per diluted share compared to $1.41 per diluted share the prior year. Reported EPS of $0.13 per diluted share compared to $1.32 per diluted share in the prior year
  • Excluding Venezuela, net sales and volume for the company increased 7 percent and 3 percent, respectively, compared to the same period in 2013
  • Global expansion of marketing plan enhancements to improve productivity, activity and retention of our members, driving a more consistent and sustainable growth model

LOS ANGELES--(BUSINESS WIRE)-- Herbalife Ltd. (NYSE: HLF) today reported third quarter net sales of $1.3 billion, reflecting an increase of 4 percent compared to the same period in 2013. Adjusted1 net income for the quarter was $125.1 million, or $1.45 per diluted share, compared to $152.1 million, or $1.41 per diluted share for the same period in 2013. On a reported basis, the company announced third quarter net income of $11.2 million, or $0.13 per diluted share, compared to $142.0 million, or $1.32 per diluted share for the same period in 2013.

Third quarter 2014 reported net income was negatively impacted by $139.5 million in pre-tax charges, or $0.97 per diluted share after tax, related to the remeasurement of Venezuelan Bolivar denominated assets and liabilities at the SICAD I and SICAD II rates, and $17.5 million in pre-tax charges, or $0.13 per diluted share after tax related to a legal reserve.

For the quarter that ended September 30, 2014, the company generated $101.9 million net operating cash flow, and purchases of property, plant and equipment in the period were $34.5 million.

Michael Johnson, chairman and CEO stated, "In the quarter we saw volume increases in two-thirds of our 91 countries, especially Russia and China. Excluding the impact of currency translation in Venezuela, the company had solid increases in both volume and net sales. We continue to implement initiatives that we believe will further strengthen our foundation and drive long-term improvements in activity, productivity and retention of our Sales Leaders. We are proud of our members' ability to grow the business in the short term while embracing changes that we believe will enhance the long-term opportunity."

_______________

1 See Schedule A - "Reconciliation of Non-GAAP Financial Measures" for more detail.

Mr. Johnson continued, "The changes we are applying globally, such as first order limits, have been tested in key markets and proven to drive positive results in terms of long term sustainable growth. China, Russia and parts of Europe are all great examples of markets that are stronger now than they were before we implemented such changes.

"While these initiatives may continue to moderate near-term volumes and sales growth, we know from our experience in those markets that have already adopted them, that they enhance the experience of our members and their customers, and position us for even greater future success. Our industry-leading Gold Standard consumer protections, changes designed to encourage our newest members to grow their businesses prudently, and a focus on growing a customer base of life-long customers all help our members become more productive and successful leaders. We know that these initiatives work, and coupled with the strength of our business model, the efficacy of our products and the power of our brand, will lead the company into its next phase of growth."

Third Quarter 2014 Key Metrics2,3

Regional Volume Point and Average Active Sales Leader Metrics

 
    Volume Points (Mil)   Average Active Sales Leaders
Region   3Q'14   Yr/Yr % Chg   3Q'14   Yr/Yr % Chg
North America   303.0  

(4%)

  77,218   4%
Asia Pacific (ex. China)   304.5   3%   76,649   5%
EMEA   199.0   15%   59,668   18%
Mexico   218.7   (0%)   66,977   4%
South & Central America   204.4   (17%)   64,279   7%
China   120.7   24%   19,550   23%
Worldwide Total   1,350.3   0%   352,248   8%
 
Regional Net Sales and FX Impact
 
    Reported Net        
    Sales (in   Growth/Decline   Growth/Decline
Region   thousands)   including FX   excluding FX
North America   $ 223,474   (2.3%)   (2.2%)
Asia Pacific (ex. China)   $ 297,896   4.9%   2.0%
EMEA   $ 204,428   12.5%   15.2%
Mexico   $ 143,927   1.9%   3.5%
South & Central America   $ 205,211   (14.9%)   (1.1%)
China   $ 181,228   32.6%   33.5%
Worldwide Total   $ 1,256,164   3.5%   6.3%

_______________

2 Supplemental tables that include additional business metrics can be found at http://www.ir.herbalife.com.

3 Worldwide Average Active Sales Leaders may not equal the sum of the Average Active Sales Leaders in each region due to the calculation being an average of Sales Leaders active in a period, not a summation, and the fact that some sales leaders are active in more than one region but are counted only once in the worldwide amount.

Outlook

Guidance for fourth quarter FY'14 includes an unfavorable impact from currency rates of approximately $0.31 compared to the prior year, inclusive of approximately $0.22 from Venezuela. Guidance for FY'15 includes a currency headwind of approximately $0.66, including approximately $0.45 from Venezuela.

Based on current business trends the company's fourth quarter fiscal 2014 and full year fiscal 2015 guidance is as follows.

    Three Months Ending   Twelve Months Ending
    December 31, 2014   December 31, 2014
   

Low

 

High

 

Low

 

High

Volume Point Growth vs 2013, ex. VZ   0.0%   3.0%   5.0%   6.0%
Volume Point Growth vs 2013   (3.0%)   0.0%   2.7%   3.5%
Net Sales Growth vs 2013   (8.0%)   (5.0%)   3.5%   4.3%
Currency Adjusted Net Sales Growth vs 2013   1.0%   4.0%   NA   NA
Diluted EPS, excluding items   $1.30   $1.40   $5.80   $5.90
Currency Adjusted EPS   $1.61   $1.71   NA   NA
Cap Ex ($ millions)   $52.0   $62.0   $170.0   $180.0
Effective Tax Rate   27.0%   29.0%   27.5%   29.5%
    Twelve Months Ending
    December 31, 2015
   

Low

 

High

Volume Point Growth vs 2014   0.0%   3.0%
Net Sales Growth vs 2014   (1.0%)   2.0%
Currency Adjusted Net Sales Growth vs 2014   3.0%   6.0%
Diluted EPS   $5.45   $5.75
Currency Adjusted EPS   $6.10   $6.40
Cap Ex ($ millions)   $145.0   $165.0
Effective Tax Rate   27.0%   29.0%
Free Cash Flow ($ millions)   $470.0   $500.0

Guidance excludes the impact of expenses primarily related to legal and advisory services relating to the company's ongoing business matters, expenses related to an FTC inquiry, and the impact of non-cash interest costs associated with the company's Convertible Notes and the expenses incurred related to the effort to recover costs related to the reaudits that occurred last year. Forward guidance is based on the average daily exchange rates of the first two weeks of October. Included in the guidance is the use of the GAAP rate for Venezuela of 50 to 1 for the balance of the year and all of 2015 and excludes the potential impact of future devaluation of the Venezuelan Bolivar and future repatriation, if any, of existing cash balances in Venezuela.

Third Quarter 2014 Earnings Conference Call

Herbalife senior management will host an investor conference call to discuss its recent financial results and provide an update on current business trends on Tuesday, November 4, 2014 at 8 a.m. PST (11 a.m. EST).

The dial-in number for this conference call for domestic callers is (877) 317-1296 and (706) 634-5671 for international callers (conference ID 7788487). Live audio of the conference call will be simultaneously webcast in the investor relations section of the company's website at http://ir.herbalife.com.

An audio replay will be available following the completion of the conference call in MP3 format or by dialing (855) 859-2056 for domestic callers or (404) 537-3406 for international callers (conference ID 7788487). The webcast of the teleconference will be archived and available on Herbalife's website.

About Herbalife Ltd.

Herbalife Ltd. (NYSE:HLF) is a global nutrition company that sells weight-management, nutrition, and personal care products intended to support a healthy lifestyle. Herbalife products are sold in more than 90 countries through and to a network of independent members. The company supports the Herbalife Family Foundation and its Casa Herbalife program to help bring good nutrition to children. Herbalife's website contains a significant amount of information about Herbalife, including financial and other information for investors at http://ir.Herbalife.com. The company encourages investors to visit its website from time to time, as information is updated and new information is posted.

FORWARD-LOOKING STATEMENTS

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, such as those disclosed or incorporated by reference in our filings with the Securities and Exchange Commission. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in our forward-looking statements include, among others, the following:

  • our relationship with, and our ability to influence the actions of, our Members;
  • improper action by our employees or Members in violation of applicable law;
  • adverse publicity associated with our products or network marketing organization, including our ability to comfort the marketplace and regulators regarding our compliance with applicable laws;
  • changing consumer preferences and demands;
  • our reliance upon, or the loss or departure of any member of, our senior management team which could negatively impact our Member relations and operating results;
  • the competitive nature of our business;
  • regulatory matters governing our products, including potential governmental or regulatory actions concerning the safety or efficacy of our products and network marketing program, including the direct selling market in which we operate;
  • legal challenges to our network marketing program;
  • risks associated with operating internationally and the effect of economic factors, including foreign exchange, inflation, disruptions or conflicts with our third party importers, pricing and currency devaluation risks, especially in countries such as Venezuela;
  • uncertainties relating to the application of transfer pricing, duties, value added taxes, and other tax regulations, and changes thereto;
  • uncertainties relating to interpretation and enforcement of legislation in China governing direct selling;
  • uncertainties relating to the interpretation, enforcement or amendment of legislation in India governing direct selling;
  • our inability to obtain the necessary licenses to expand our direct selling business in China;
  • adverse changes in the Chinese economy, Chinese legal system or Chinese governmental policies;
  • our dependence on increased penetration of existing markets;
  • contractual limitations on our ability to expand our business;
  • our reliance on our information technology infrastructure and outside manufacturers;
  • the sufficiency of trademarks and other intellectual property rights;
  • product concentration;
  • changes in tax laws, treaties or regulations, or their interpretation;
  • taxation relating to our Members;
  • product liability claims;
  • whether we will purchase any of our shares in the open markets or otherwise; and
  • share price volatility related to, among other things, speculative trading and certain traders shorting our common shares.

We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

RESULTS OF OPERATIONS:

Herbalife Ltd. and Subsidiaries
Condensed Consolidated Statements of Income
(In thousands, except per share amounts)
(Unaudited)
         
    Three Months Ended   Nine Months Ended
     

9/30/2014

   

9/30/2013

 

9/30/2014

 

9/30/2013

                 
North America   $ 223,474     $ 228,660   $ 721,935   $ 697,697
Mexico     143,927       141,243     435,248     419,770
South and Central America     205,211       241,235     653,186     683,112
EMEA     204,428       181,738     642,933     537,609
Asia Pacific     297,896       284,017     884,583     895,003
China     181,228       136,650     487,128     323,238
Worldwide net sales     1,256,164       1,213,543     3,825,013     3,556,429
Cost of Sales (1)     254,941       238,415     763,327     711,616
Gross Profit     1,001,223       975,128     3,061,686     2,844,813
Royalty Overrides     363,859       373,241     1,136,452     1,116,821
Selling, General and Administrative Expenses (2)     609,722       409,747     1,573,701     1,174,574
Operating Income     27,642       192,140     351,533     553,418
Interest Expense, net     19,864       4,726     56,231     15,658
Other Expense, net (3)     9,831       -     12,992     -
(Loss) Income before income taxes     (2,053 )     187,414     282,310     537,760
Income Taxes     (13,301 )     45,464     76,902     133,775
Net Income     11,248       141,950     205,408     403,985
                 
Basic Shares     81,927       102,200     87,754     103,096
Diluted Shares     86,201       107,777     92,619     107,759
                 
Basic EPS   $ 0.14     $ 1.39   $ 2.34   $ 3.92
Diluted EPS   $ 0.13     $ 1.32   $ 2.22   $ 3.75
                 
Dividends declared per share   $ -     $ 0.30   $ 0.30   $ 0.90
 
                 

(1) As discussed in Note 2 of the quarterly report on Form 10-Q for the quarter ended September 30, 2014, Cost of Sales includes $7.6 million of inventory write downs related to Venezuela.

(2) As discussed in Note 2 of the quarterly report on Form 10-Q for the quarter ended September 30, 2014, Selling, General and Administrative Expenses includes $17.1 million and $98.0 million pre-tax unfavorable impact related to the remeasurement of Venezuela Bolivar-denominated assets and liabilities at the SICAD I and SICAD II rate, respectively, and $7.0 million loss on Venezuela asset impairment for the three months ended September 30, 2014; and includes $103.4 million and $98.0 million pre-tax unfavorable impact related to the remeasurement of Venezuela Bolivar-denominated assets and liabilities at the SICAD I and SICAD II rate, respectively, and $7.0 million loss on Venezuela asset impairment for the nine months ended September 30, 2014.

(3) As discussed in Note 2 of the quarterly report on Form 10-Q for the quarter ended September 30, 2014, Other Expense, net relates to the impairment of investments in Bolivar-denominated bonds.

 

 
Herbalife Ltd. and Subsidiaries
Condensed Consolidated Balance Sheets
(In thousands)
(Unaudited)
 
    Sep 30,   Dec 31,
     

2014

     

2013

 
         
ASSETS        
Current Assets:        
Cash & cash equivalents   $ 678,134     $ 972,974  
Receivables, net     100,560       100,326  
Inventories     367,827       351,201  
Prepaid expenses and other current assets     208,589       148,774  
Deferred income taxes     81,722       69,845  
Total Current Assets     1,436,832       1,643,120  
         
Property, net     358,983       318,860  
Deferred compensation plan assets     27,102       26,821  
Deferred financing cost, net     23,837       4,896  
Other assets     101,730       63,713  
Marketing related intangibles and other intangible assets, net     310,524       310,801  
Goodwill     105,490       105,490  
Total Assets   $ 2,364,498     $ 2,473,701  
         
         
LIABILITIES AND SHAREHOLDERS' EQUITY        
Current Liabilities:        
Accounts payable   $ 93,561     $ 82,665  
Royalty overrides     257,775       266,952  
Accrued compensation     85,451       111,905  
Accrued expenses     273,074       267,501  
Current portion of long-term debt     100,000       81,250  
Advance sales deposits     89,499       68,079  
Income taxes payable     28,674       43,826  
Total Current Liabilities     928,034       922,178  
         
Non-current liabilities        
Long-term debt, net of current portion     1,727,919       850,019  
Deferred compensation plan liability     41,805       37,226  
Deferred income taxes     25,719       66,026  
Other non-current liabilities     61,582       46,806  
Total Liabilities     2,785,059       1,922,255  
         
Contingencies        
         
Shareholders' (deficit) equity:        
Common shares     92       101  
Paid-in capital in excess of par value     406,822       323,860  
Accumulated other comprehensive loss     (58,785 )     (19,794 )
(Accumulated deficit) retained earnings     (768,690 )     247,279  
Total Shareholders' (Deficit) Equity     (420,561 )     551,446  
         
Total Liabilities and Shareholders' (Deficit) Equity   $ 2,364,498     $ 2,473,701  

 

 
Herbalife Ltd. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(In thousands)

(Unaudited)

 

 

   
    Nine Months Ended
     

9/30/2014

     

9/30/2013

 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net income   $ 205,408     $ 403,985  

Adjustments to reconcile net income to net cash provided by operating activities:

       
Depreciation and amortization     69,191       63,207  
(Excess) deficiency in tax benefits from share-based payment arrangements     (4,176 )     2,586  
Share-based compensation expenses     34,431       21,882  
Non-cash interest expense     31,179       1,937  
Deferred income taxes     (59,022 )     (7,532 )
Inventory write-downs     17,729       17,536  
Unrealized foreign exchange transaction loss (gain)     4,032       585  
Foreign exchange loss relating to Venezuela     200,294       15,116  
Impairments and write-downs relating to Venezuela     27,514       -  
Other     3,060       1,661  
Changes in operating assets and liabilities:        
Receivables     (5,388 )     1,624  
Inventories     (58,724 )     (37,311 )
Prepaid expenses and other current assets     (59,211 )     (15,330 )
Other assets     (8,794 )     (678 )
Accounts payable     15,407       8,569  
Royalty overrides     4,385       13,959  
Accrued expenses and accrued compensation     11,822       65,868  
Advance sales deposits     27,446       27,038  
Income taxes     (11,665 )     (13,313 )
Deferred compensation plan liability     4,579       5,595  
NET CASH PROVIDED BY OPERATING ACTIVITIES     449,497       576,984  
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchases of property, plant and equipment     (139,970 )     (91,782 )
Proceeds from sale of property, plant and equipment     23       121  
Investments in Venezuelan bonds     (11,818 )     -  
NET CASH USED IN INVESTING ACTIVITIES     (151,765 )     (91,661 )
CASH FLOWS FROM FINANCING ACTIVITIES        
Dividends paid     (30,400 )     (92,651 )
Dividends received     3,416       -  
Payments for Capped Call Transactions     (123,825 )     -  
Borrowings from senior secured credit facility and other debt     -       763,232  
Proceeds from senior convertible notes     1,150,000       -  
Principal payments on senior secured credit facility and other debt     (56,250 )     (300,733 )
Issuance costs relating to long-term debt and senior convertible notes     (28,927 )     -  
Share repurchases     (1,278,420 )     (275,821 )
Excess (deficiency in) tax benefits from share-based payment arrangements     4,176       (2,586 )
Proceeds from exercise of stock options and sale of stock under employee stock purchase plan     2,401       975  
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES     (357,829 )     92,416  
EFFECT OF EXCHANGE RATE CHANGES ON CASH     (234,743 )     (18,725 )
NET CHANGE IN CASH AND CASH EQUIVALENTS     (294,840 )     559,014  
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD     972,974       333,534  
CASH AND CASH EQUIVALENTS, END OF PERIOD     678,134       892,548  
CASH PAID DURING THE PERIOD        
Interest paid   $ 31,512     $ 18,005  
Income taxes paid   $ 152,698     $ 163,843  
NON CASH ACTIVITIES        
Accrued capital expenditures   $ 10,939     $ 7,705  

 

SUPPLEMENTAL INFORMATION

SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
(unaudited and unreviewed), (Dollars in Thousand, Except Per Share Data)

In addition to its reported results, the Company has included in the tables below adjusted results that the Securities and Exchange Commission defines as "non-GAAP financial measures." Management believes that such non-GAAP financial measures, when read in conjunction with the Company's reported results, can provide useful supplemental information for investors in analyzing period to period comparisons of the Company's results.

The following is a reconciliation of net income, presented and reported in accordance with U.S. generally accepted accounting principles, to net income adjusted for certain items:

 
                 
    Three Months Ended   Nine Months Ended
     

9/30/14

   

9/30/13

 

9/30/14

 

9/30/13

    (in thousands)
                 
Net income, as reported   $ 11,248     $ 141,950   $ 205,408   $ 403,985
Remeasurement and impairment losses relating to Venezuela(1)(2)     83,717       12     152,878     8,319
Expenses incurred responding to attacks on the Company's business model (1)(3)     4,543       5,485     13,459     20,589
Expenses incurred for the re-audit of 2010 to 2012 financial statements (1)(4)     -       4,640     -     7,301
Expenses related to the FTC inquiry (1)(5)     2,776       -     6,541     -
Expenses incurred for the recovery of re-audit fees (1)(6)     (33 )     -     378     -

Non-cash interest expense and amortization of non-cash issuance costs (7)

    9,927       -     25,936     -
Legal reserve for the Bostick case (1)(8)     11,279       -     11,279     -
Impairment of newly acquired defective manufacturing equipment (1)(9)     1,651       -     1,651     -
Net income, as adjusted   $ 125,108     $ 152,087   $ 417,530   $ 440,194
 
                 
                 

The following is a reconciliation of diluted earnings per share, presented and reported in accordance with U.S. generally accepted accounting principles, to diluted earnings per share adjusted for certain items:

 

       
 
                 
    Three Months Ended   Nine Months Ended
     

9/30/14

   

9/30/13

 

9/30/14

 

9/30/13

                 
Diluted earnings per share, as reported   $ 0.13     $ 1.32   $ 2.22   $ 3.75
Remeasurement loss relating to Venezuela(1)(2)     0.97       -     1.65     0.08
Expenses incurred responding to attacks on the Company's business model (1)(3)     0.05       0.05     0.15     0.19
Expenses incurred for the re-audit of 2010 to 2012 financial statements (1)(4)     -       0.04     -     0.07
Expenses related to the FTC inquiry (1)(5)     0.03       -     0.07     -
Expenses incurred for the recovery of re-audit fees (1)(6)     -       -     -     -

Non-cash interest expense and amortization of non-cash issuance costs (7)

    0.12       -     0.28     -
Legal reserve for the Bostick case (1)(8)     0.13       -     0.12     -
Impairment of newly acquired defective manufacturing equipment (1)(9)     0.02       -     0.02     -

Diluted earnings per share, as adjusted (10)

  $ 1.45     $ 1.41   $ 4.51   $ 4.08
 
                 
                 

(1) Based on interim income tax reporting rules, these expenses are not considered discrete items. As a result, the Company's full year effective tax rate is impacted by these items. When applying the full year effective tax rate to year-to-date income, the Company's year-to-date tax provision recorded with respect to these non-GAAP adjustments is different from the forecasted full-year tax provision impact of these items. As a consequence, adjustments to the year-to-date and quarterly tax impacts will be recorded as the adjusted full year effective tax rate is applied to income in subsequent periods. Additionally, adjustments to items unrelated to these non-GAAP adjustments may have an effect on the income tax impact of these non-GAAP adjustments in subsequent periods. The Company plans to update the income tax impact of these items in subsequent interim reporting periods.

(2) Net of $55,801 and $(12) tax benefit for the three months ended Sept. 30, 2014 and 2013, respectively; and net of $76,118 and $6,796 tax benefit for the nine months ended Sept. 30, 2014 and 2013, respectively.

(3) Net of $1,461 and $773 tax benefit for the three months ended Sept. 30, 2014 and 2013, respectively; and net of $4,827 and $3,241 tax benefit for the nine months ended Sept. 30, 2014 and 2013, respectively.

(4) Net of $1,533 and $2,329 tax benefit for the three and nine months ended Sept. 30, 2013, respectively.
(5) Net of $1,817 and $4,095 tax benefit for the three and nine months ended Sept. 30, 2014, respectively.
(6) Net of $93 and $96 tax benefit for the three and nine months ended Sept. 30, 2014, respectively.
(7) Relates to non-cash expense on our convertible notes and prepaid forward share repurchase contract.
(8) Net of $6,221 tax benefit for the three and nine months ended Sept. 30, 2014.
(9) Net of $913 tax benefit for the three and nine months ended Sept. 30, 2014.
(10) Amounts may not total due to rounding.

 

The following is a reconciliation of total long-term debt to net debt:

 
   

9/30/14

   

12/31/13

 
         
Total long-term debt (current and long-term portion)   $ 1,827,919   $ 931,269  
Less: Cash and cash equivalents     678,134     972,974  
Net debt   $ 1,149,785   $ (41,705 )

 

Herbalife Ltd.
Media Contact:
Julian Cacchioli
VP, Worldwide Corp. Comm.
213-745-0519
or
Investor Contact:
Amy Greene
SVP, Investor Relations
213-745-0474

Source: Herbalife Ltd.

 

 

News Provided by Acquire Media